Global Clinical Chemistry Analyzer Market By Measurement Technologies(Photometric and Colorimetric Testing, Ion-Selective Potentiometry, Latex Agglutination, Others) By Type Automated, Benchtop Analyzer, others) By Substances(Serum, Plasma, Urine, Other body fluids) By Photometric Throughput(400/800 with ISE, 800/1,200 with ISE, Up to 8,000 test/hour, Up to 9,800 test/hour with dual ISE, Others) By Sample Load Capacity (80 (8 racks x 10 samples), 22 samples by carousel, 150 (15 racks x 10 samples), 22 samples by carousel, 400 samples (2 x 20 rack set), Others) By Application(Diabetes, Testing for metabolic functions or cardiac markers, Drugs-of-abuse testing, Others) By End User(Physician Office Laboratory, Hospital Laboratory, Point-of-care clinics, University and Research Institutes, Veterinary Laboratories and Food and Wine Laboratories, Core Laboratory, Reference Laboratory, Integrated Delivery Network, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Clinical chemistry is a branch of medicine that focuses on examining biological matter or bodily fluids in order to provide timely, relevant and precise diagnostic information about the human body's clinical condition. Many tests are still important in clinical chemistry today, but the way they're done has changed dramatically. In the recent years, due to technological innovations, improved manufacturing methods, the integration of software into the lab environment and medical discoveries are all driving improvements in analyzer design and performance. Modern clinical chemistry is built on the foundation of traditional manual laboratory tests. However, as technology has progressed, testing methods have developed, and various tests are now being performed in automated laboratories utilising complex devices such as chemical analyzers. The clinical chemistry analyzer market has seen a steady stream of developments, largely due to technological advancements. Clinical chemistry analyzers' future is projected to be shaped by ongoing R&D operations, as well as the integration of new software technologies in clinical laboratories. Furthermore, manufacturers are rapidly manufacturing smaller clinical chemistry analyzers, which has opened the floodgates for increased testing capabilities. The latest generation of clinical chemistry analyzers are helping hospitals, point-of-care diagnostic centres, and research laboratories increase workflow efficiency which is driving the growth of the market globally.
In terms of revenue, global clinical chemistry analyzer market was valued at US$ 12,123 Mn in 2021 growing at a CAGR of 4.8% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Clinical Chemistry Analyzer Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook:
Based on type, the market is segmented into automated, benchtop and others. Benchtop clinical chemistry analyser registered for the highest share in the market in the year 2021. Benchtop clinical chemistry analyzers are equipment that perform tests to identify whether or not a specific substance is present in a sample. These clinical chemistry analyzers are used in low to medium volume laboratories to perform medical tests, quality control testing on home chemicals like detergent, food and beverage analysis, and water testing. A bench top clinical chemistry analyzer can perform a variety of analyses, including random access analysis, batch analysis, and photometric analysis. Thus the above factors mentioned are boosting the growth of this segment in the clinical chemistry analyzer market globally.
By Measurement Technologies:
Clinical chemistry analyzers have various measuring technologies such as photometric and colorimetric testing, Ion-selective potentiometry, latex agglutination and others. Photometric and colorimetric testing are the most common measuring technologies used in clinical chemistry analyzer market, which determines the concentration of analyte in the samples. To induce a reaction that results in a colour, the sample is combined with the right reagent. The strength of the colour produced is determined by the analyte concentration. For instance, the RX daytona from Randox Laboratories Ltd offers a clinical chemistry analyzers, runs colorimetric and UV photometric methods at eight different wavelengths and performs 270 photometric tests per hour.
Photometric Throughput Outlook:
Based on the photometric throughput, the clinical chemistry analyzer market is segmented into 400/800 with ISE, 800/1,200 with ISE, Up to 8,000 test/hour, Up to 9,800 test/hour with dual ISE and others. Throughput can be understood as the amount of material or items passing through the analyser so that the cost per sample is reduced and large volumes of samples are being analysed. Tests per hour are used to measure throughput, however the rate varies based on the test method. Colorimetric examinations are frequently used in high-throughput machines due to their low incubation durations. High throughput may be required in a high-volume hospital laboratory and thus to cater to these demands manufacturers are innovating analyzers. For instance, Beckman Coulter offers 400 samples and a maximum throughput of 9800 tests/hr and up to 1800 ISE tests/hr.
Application Outlook:
Based on the application segment, the global clinical chemistry analyzer market is segmented into diabetes, testing for metabolic functions or cardiac markers, drugs-of-abuse testing and others. Diabetes had the highest share in the market in the year 2021. Diabetes is one of the common and highly prelevant illness amongst a large population According to the International Diabetes Federation, 537 million individuals (20-79 years) are estimated to have diabetes, with the overall number of diabetics expected to rise to 643 million by 2030 and 783 million by 2045. Thus to cater these increased tests for diabetes, leading players in the market are focused on providing advanced technologies for diabetes tests. For instance, EKF Diagnostics Holdings plc offers semi-automated point-of-care analyzer for measuring glycated hemoglobin (HbA1c). These analyzers were created to meet the needs of diabetic clinics and laboratories in environments that require minimal operating costs and ease of use.
End User Outlook:
Based on the end user segment, the clinical chemistry analyzer market is segmented into physician office laboratory, hospital laboratory, point-of-care clinics, university and research institutes, veterinary laboratories and food and wine laboratories, core laboratory, reference laboratory, integrated delivery network and others. Hospital laboratory had the highest share in the market in the year 2021. Hospitals are highly investing into advanced devices such as clinical analysers to have extremely efficient results for large volumes of tests being carried out. For instance, Siemens Healthcare Limited, offers clinical chemistry analyser which helps to improve workflow and turnaround time along with greater connectivity to automation and an extensive menu for tests.
The use of point-of-care testing (POCT) in clinical settings is steadily rising in many health-care systems. As point of care clinics provide the ability to test patients outside of the central laboratory such as operating theatre, critical care unit, maternity unit, on emergency vehicles (ambulances) the demand has risen considerably over the last few years. Leading players in the clinical chemistry analyzer market are introducing affordable and compact clinical chemistry analyzers for point of care clinics wherein a multi-analyte detection tool that allows for rapid, easy, and simultaneous monitoring of biomarkers in a micro-sample with combination of various tests reagent discs, such as the complications of diabetes panel, renal panel, liver panel, cardiovascular panel and others. Moreover these analyzers have a strong potential for future extension to counter-sales (over medicine and individualized healthcare management, based on its ease of use, compact size, and cost-effective advantages.
Region Outlook:
Based on the regions, North America accounted for the highest share in the global clinical chemistry analyser market in 2021. The demand for clinical chemistry analyzers is being fuelled by an increase in the incidence of lifestyle diseases such as heart disease and diabetes, as well as rise in number of infectious diseases. Moreover the use of home-based point-of-care devices, and technological advancements in the development of advanced, fast, and easy-to-use devices has led to the rise in growth of clinical chemistry analyzer market.
Competitive Landscape
The report provides both, qualitative and quantitative research of clinical chemistry analyzer market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global clinical chemistry analyzer market are:
- Abbott
- Beckman Coulter, Inc.
- Cardinal Health
- F. Hoffmann-La Roche Ltd.
- Hitachi High-Tech Corporation
- HORIBA Medical
- Mindray Bio-Medical Electronics Co., Ltd.
- MNCHIP Technologies Co., Ltd.
- Ortho Clinical Diagnostics
- Randox Laboratories Ltd.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc
- Trivitron Healthcare
- Other Industry Participants
Global Clinical Chemistry Analyzer Market:
By Measurement Technologies
- Photometric and colorimetric testing
- Ion-selective potentiometry
- Latex agglutination
- Others
By Type
- Automated
- Benchtop Analyzer
- Others
By Substances
- Serum
- Plasma
- Urine
- Other body fluids
By Photometric Throughput
- 400/800 with ISE
- 800/1,200 with ISE
- Up to 8,000 test/hour
- Up to 9,800 test/hour with dual ISE
- Others
By Sample Load Capacity
- 80 (8 racks x 10 samples), 22 samples by carousel
- 150 (15 racks x 10 samples), 22 samples by carousel
- 400 samples (2 x 20 rack set)
- Others
By Application
- Diabetes
- Testing for metabolic functions or cardiac markers
- Drugs-of-abuse testing
- Others
By End User
- Physician Office Laboratory
- Hospital Laboratory
- Point-of-care clinics
- University and Research Institutes, Veterinary Laboratories and Food and Wine Laboratories
- Core Laboratory
- Reference Laboratory
- Integrated Delivery Network
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table
of Contents
1. Market Scope
1.1.
Market Segmentation
1.2.
Years Considered
1.2.1.
Historic
Years: 2015 - 2020
1.2.2.
Base
Year: 2021
1.2.3.
Forecast Years: 2022 – 2030
2.
Key Target Audiences
3.
Research Methodology
3.1.
Primary Research
3.1.1.
Research Questionnaire
3.1.2.
Global
Percentage Breakdown
3.1.3.
Primary
Interviews: Key Opinion Leaders (KOLs)
3.2.
Secondary Research
3.2.1.
Paid Databases
3.2.2.
Secondary Sources
3.3.
Market Size Estimates
3.3.1.
Top-Down Approach
3.3.2.
Bottom-Up Approach
3.4.
Data
Triangulation Methodology
3.5.
Research Assumptions
4.
Recommendations and Insights from AMI’s Perspective**
5.
Holistic Overview of Clinical Chemistry Analyzer Market
6.
Market Synopsis: Clinical
Chemistry Analyzer Market
7. Clinical Chemistry Analyzer Market Analysis: Qualitative Perspective
7.1.
Introduction
7.1.1.
Product Definition
7.1.2.
Industry Development
7.2.
Market Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.2.4.
Challenges
7.3.
Trends
in Clinical Chemistry Analyzer Market
7.4.
Market Determinants Radar Chart
7.5.
Macro-Economic
and Micro-Economic Indicators: Clinical Chemistry Analyzer Market
7.6.
Industry
Gross Margin Overview
7.7.
Porter’s
Five Force Analysis
7.8.
Impact
of Covid-19 on Clinical Chemistry Analyzer Market
8.
Global Clinical Chemistry
Analyzer Market Analysis and Forecasts,
2022 – 2030
8.1.
Overview
8.1.1.
Global
Clinical Chemistry Analyzer Market Revenue (US$ Mn)
8.2. Global Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement Technologies
8.2.1.
Photometric
and colorimetric testing
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2021
8.2.1.3. Market
Forecast, 2022
– 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation,
2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022
– 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation,
2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022
– 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation,
2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022
– 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation,
2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022
– 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation,
2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022
– 2030
8.2.2.
Ion-selective potentiometry
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2021
8.2.2.3. Market
Forecast, 2022
– 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation,
2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022
– 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation,
2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022
– 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation,
2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022
– 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation,
2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022
– 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation,
2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022
– 2030
8.2.3.
Latex agglutination
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2021
8.2.3.3. Market
Forecast, 2022
– 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
|
|
8.2.3.5.1. |
North
America 8.2.3.5.1.1. Market
Estimation,
2015 - 2021 8.2.3.5.1.2. Market
Forecast,
2022 – 2030 |
|
8.2.3.5.2. |
Europe 8.2.3.5.2.1. Market
Estimation,
2015 - 2021 8.2.3.5.2.2. Market
Forecast,
2022 – 2030 |
|
|
8.2.3.5.3. |
Asia Pacific 8.2.3.5.3.1. Market
Estimation,
2015 - 2021 8.2.3.5.3.2. Market
Forecast,
2022 – 2030 |
|
|
8.2.3.5.4. |
Middle East and Africa 8.2.3.5.4.1. Market
Estimation,
2015 - 2021 8.2.3.5.4.2. Market
Forecast,
2022 – 2030 |
|
|
8.2.4. Others |
8.2.3.5.5. |
Latin America 8.2.3.5.5.1. Market
Estimation,
2015 - 2021 8.2.3.5.5.2. Market
Forecast,
2022 – 2030 |
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 - 2021
8.2.4.3. Market
Forecast, 2022
– 2030
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation,
2015 - 2021
8.2.4.5.1.2. Market
Forecast, 2022
– 2030
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation,
2015 - 2021
8.2.4.5.2.2. Market
Forecast, 2022
– 2030
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation,
2015 - 2021
8.2.4.5.3.2. Market
Forecast, 2022
– 2030
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation,
2015 - 2021
8.2.4.5.4.2. Market
Forecast, 2022
– 2030
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation,
2015 - 2021
8.2.4.5.5.2. Market
Forecast, 2022
– 2030
8.3. Key Segment for Channeling Investments
8.3.1.
By
Measurement Technologies
9.
Global Clinical Chemistry
Analyzer Market Analysis and Forecasts,
2022 – 2030
9.1.
Overview
9.2.
Global
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
9.2.1.
Automated
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2021
9.2.1.3. Market
Forecast, 2022
– 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation,
2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022
– 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation,
2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022
– 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation,
2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022
– 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation,
2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022
– 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation,
2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022
– 2030
9.2.2. Benchtop Analyzer
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2021
9.2.2.3. Market
Forecast, 2022
– 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
|
|
9.2.2.5.1. |
North
America 9.2.2.5.1.1. Market
Estimation,
2015 - 2021 9.2.2.5.1.2. Market
Forecast,
2022 – 2030 |
|
9.2.2.5.2. |
Europe 9.2.2.5.2.1. Market
Estimation,
2015 - 2021 9.2.2.5.2.2. Market
Forecast,
2022 – 2030 |
|
|
9.2.2.5.3. |
Asia Pacific 9.2.2.5.3.1. Market
Estimation,
2015 - 2021 9.2.2.5.3.2. Market
Forecast,
2022 – 2030 |
|
|
9.2.2.5.4. |
Middle East and Africa 9.2.2.5.4.1. Market
Estimation,
2015 - 2021 9.2.2.5.4.2. Market
Forecast,
2022 – 2030 |
|
|
9.2.2.5.5. |
Latin America 9.2.2.5.5.1. Market
Estimation,
2015 - 2021 9.2.2.5.5.2. Market
Forecast,
2022 – 2030 |
|
|
9.2.3.
Others |
|
|
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2021
9.2.3.3. Market
Forecast, 2022
– 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation,
2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022
– 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation,
2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022
– 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation,
2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022
– 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation,
2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022
– 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation,
2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022
– 2030
9.3. Key Segment for Channeling Investments
9.3.1.
By Type
10. Global
Clinical Chemistry Analyzer Market
Analysis and Forecasts, 2022 – 2030
10.1.
Overview
10.2. Global Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
10.2.1.
Serum
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2021
10.2.1.3. Market
Forecast, 2022
– 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation,
2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022
– 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation,
2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022
– 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation,
2015 - 2021
10.2.1.5.3.2.
Market Forecast,
2022 – 2030 10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation,
2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022
– 2030
10.2.1.5.5.
Latin America
10.2.2.
Plasma
10.2.2.1. Definition
10.2.1.5.5.1. Market
Estimation,
2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022
– 2030
10.2.2.2. Market
Estimation and Penetration, 2015 - 2021
10.2.2.3. Market
Forecast, 2022
– 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation,
2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022
– 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation,
2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022
– 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation,
2015 - 2021
10.2.2.5.3.2.
Market Forecast,
2022 – 2030 10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation,
2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022
– 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation,
2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022
– 2030
10.2.3.
Urine
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 - 2021
10.2.3.3. Market
Forecast, 2022
– 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation,
2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022
– 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation,
2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022
– 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation,
2015 - 2021
10.2.3.5.3.2.
Market Forecast,
2022 – 2030 10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation,
2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022
– 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation,
2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022
– 2030
10.2.4.
Other
body fluids
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 - 2021
10.2.4.3. Market
Forecast, 2022
– 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation,
2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022
– 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation,
2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022
– 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation,
2015 - 2021
10.2.4.5.3.2.
Market Forecast,
2022 – 2030 10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015
- 2021
10.2.4.5.4.2. Market
Forecast, 2022
– 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation,
2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022
– 2030
10.3. Key Segment for
Channeling Investments
10.3.1.
By Substances
11. Global
Clinical Chemistry Analyzer Market
Analysis and Forecasts, 2022 – 2030
11.1.
Overview
11.2. Global Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
11.2.1.
400/800
with ISE
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 - 2021
11.2.1.3. Market
Forecast, 2022
– 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation,
2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022
– 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation,
2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022
– 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation,
2015 - 2021
11.2.1.5.3.2.
Market Forecast,
2022 – 2030 11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation,
2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022
– 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation,
2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022
– 2030
11.2.2. 800/1,200 with ISE
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 - 2021
11.2.2.3. Market
Forecast, 2022
– 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation,
2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022
– 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation,
2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022
– 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation,
2015 - 2021
11.2.2.5.3.2.
Market Forecast,
2022 – 2030 11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation,
2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022
– 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation,
2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022
– 2030
11.2.3. Up to 8,000 test/hour
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 - 2021
11.2.3.3. Market
Forecast, 2022
– 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation,
2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022
– 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation,
2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022
– 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation,
2015 - 2021
11.2.3.5.3.2.
Market Forecast,
2022 – 2030 11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation,
2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022
– 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation,
2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022
– 2030
11.2.4. Up to 9,800 test/hour with dual
ISE
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 - 2021
11.2.4.3. Market
Forecast, 2022
– 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation,
2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022
– 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation,
2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022
– 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation,
2015 - 2021
11.2.4.5.3.2.
Market Forecast,
2022 – 2030 11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation,
2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022
– 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation,
2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022
– 2030
11.2.5. Others
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 - 2021
11.2.5.3. Market
Forecast, 2022
– 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation,
2015 - 2021
11.2.5.5.1.2. Market
Forecast, 2022
– 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation,
2015 - 2021
11.2.5.5.2.2. Market
Forecast, 2022
– 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation,
2015 - 2021
11.2.5.5.3.2.
Market Forecast,
2022 – 2030 11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation,
2015 - 2021
11.2.5.5.4.2. Market
Forecast, 2022
– 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation,
2015 - 2021
11.2.5.5.5.2. Market
Forecast, 2022
– 2030
11.3. Key Segment for
Channeling Investments
11.3.1.
By
Photometric Throughput
12. Global
Clinical Chemistry Analyzer Market
Analysis and Forecasts, 2022 – 2030
12.1.
Overview
12.2. Global Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
12.2.1.
80
(8 racks x 10 samples), 22 samples by carousel
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 - 2021
12.2.1.3. Market
Forecast, 2022
– 2030
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation,
2015 - 2021
12.2.1.5.1.2. Market
Forecast, 2022
– 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation,
2015 - 2021
12.2.1.5.2.2. Market
Forecast, 2022
– 2030
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation,
2015 - 2021
12.2.1.5.3.2.
Market Forecast,
2022 – 2030 12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation,
2015 - 2021
12.2.1.5.4.2. Market
Forecast, 2022
– 2030
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation,
2015 - 2021
12.2.1.5.5.2. Market
Forecast, 2022
– 2030
12.2.2.
150
(15 racks x 10 samples), 22 samples
by carousel
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 - 2021
12.2.2.3. Market
Forecast, 2022
– 2030
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation,
2015 - 2021
12.2.2.5.1.2. Market
Forecast, 2022
– 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation,
2015 - 2021
12.2.2.5.2.2. Market
Forecast, 2022
– 2030
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation,
2015 - 2021
12.2.2.5.3.2.
Market Forecast,
2022 – 2030 12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation,
2015 - 2021
12.2.2.5.4.2. Market
Forecast, 2022
– 2030
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation,
2015 - 2021
12.2.2.5.5.2. Market
Forecast, 2022
– 2030
12.2.3.
400
samples (2 x 20 rack set)
12.2.3.1. Definition
12.2.3.2. Market
Estimation and Penetration, 2015 - 2021
12.2.3.3. Market
Forecast, 2022
– 2030
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market
Estimation,
2015 - 2021
12.2.3.5.1.2. Market
Forecast, 2022
– 2030
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation,
2015 - 2021
12.2.3.5.2.2. Market
Forecast, 2022
– 2030
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market
Estimation,
2015 - 2021
12.2.3.5.3.2.
Market Forecast,
2022 – 2030 12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market
Estimation,
2015 - 2021
12.2.3.5.4.2. Market
Forecast, 2022
– 2030
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market
Estimation,
2015 - 2021
12.2.3.5.5.2. Market
Forecast, 2022
– 2030
12.2.4.
Others
12.2.4.1. Definition
12.2.4.2. Market
Estimation and Penetration, 2015 - 2021
12.2.4.3. Market
Forecast, 2022
– 2030
12.2.4.4. Compound Annual Growth Rate (CAGR)
12.2.4.5. Regional Bifurcation
12.2.4.5.1. North America
12.2.4.5.1.1. Market
Estimation,
2015 - 2021
12.2.4.5.1.2. Market
Forecast, 2022
– 2030
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation,
2015 - 2021
12.2.4.5.2.2. Market
Forecast, 2022
– 2030
12.2.4.5.3. Asia Pacific
12.2.4.5.3.1. Market
Estimation,
2015 - 2021
12.2.4.5.3.2.
Market Forecast,
2022 – 2030 12.2.4.5.4. Middle East and Africa
12.2.4.5.4.1. Market
Estimation,
2015 - 2021
12.2.4.5.4.2. Market
Forecast, 2022
– 2030
12.2.4.5.5. Latin America
12.2.4.5.5.1. Market
Estimation,
2015 - 2021
12.2.4.5.5.2. Market
Forecast, 2022
– 2030
12.3. Key Segment for
Channeling Investments
12.3.1.
By
Sample Load Capacity
13. Global
Clinical Chemistry Analyzer Market
Analysis and Forecasts, 2022 – 2030
13.1.
Overview
13.2. Global Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
13.2.1.
Diabetes
13.2.1.1. Definition
13.2.1.2. Market
Estimation and Penetration, 2015 - 2021
13.2.1.3. Market
Forecast, 2022
– 2030
13.2.1.4. Compound Annual Growth Rate (CAGR)
13.2.1.5. Regional Bifurcation
13.2.1.5.1. North America
13.2.1.5.1.1. Market
Estimation,
2015 - 2021
13.2.1.5.1.2. Market
Forecast, 2022
– 2030
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation,
2015 - 2021
13.2.1.5.2.2. Market
Forecast, 2022
– 2030
13.2.1.5.3. Asia Pacific
13.2.1.5.3.1. Market
Estimation,
2015 - 2021
13.2.1.5.3.2.
Market Forecast,
2022 – 2030 13.2.1.5.4. Middle East and Africa
13.2.1.5.4.1. Market
Estimation,
2015 - 2021
13.2.1.5.4.2. Market
Forecast, 2022
– 2030
13.2.1.5.5. Latin America
13.2.1.5.5.1. Market
Estimation,
2015 - 2021
13.2.1.5.5.2. Market
Forecast, 2022
– 2030
13.2.2.
Testing
for metabolic functions or cardiac markers
13.2.2.1. Definition
13.2.2.2. Market
Estimation and Penetration, 2015 - 2021
13.2.2.3. Market
Forecast, 2022
– 2030
13.2.2.4. Compound Annual Growth Rate (CAGR)
13.2.2.5. Regional Bifurcation
13.2.2.5.1. North America
13.2.2.5.1.1. Market
Estimation,
2015 - 2021
13.2.2.5.1.2. Market
Forecast, 2022
– 2030
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation,
2015 - 2021
13.2.2.5.2.2. Market
Forecast, 2022
– 2030
13.2.2.5.3. Asia Pacific
13.2.2.5.3.1. Market
Estimation,
2015 - 2021
13.2.2.5.3.2.
Market Forecast,
2022 – 2030 13.2.2.5.4. Middle East and Africa
13.2.2.5.4.1. Market
Estimation,
2015 - 2021
13.2.2.5.4.2. Market
Forecast, 2022
– 2030
13.2.2.5.5. Latin America
13.2.2.5.5.1. Market
Estimation,
2015 - 2021
13.2.2.5.5.2. Market
Forecast, 2022
– 2030
13.2.3.
Drugs-of-abuse testing
13.2.3.1. Definition
13.2.3.2. Market
Estimation and Penetration, 2015 - 2021
13.2.3.3. Market
Forecast, 2022
– 2030
13.2.3.4. Compound Annual Growth Rate (CAGR)
13.2.3.5. Regional Bifurcation
13.2.3.5.1. North America
13.2.3.5.1.1. Market
Estimation,
2015 - 2021
13.2.3.5.1.2. Market
Forecast, 2022
– 2030
13.2.3.5.2. Europe
13.2.3.5.2.1. Market
Estimation,
2015 - 2021
13.2.3.5.2.2. Market
Forecast, 2022
– 2030
13.2.3.5.3. Asia Pacific
13.2.3.5.3.1. Market
Estimation,
2015 - 2021
13.2.3.5.3.2.
Market Forecast,
2022 – 2030 13.2.3.5.4. Middle East and Africa
13.2.3.5.4.1. Market
Estimation,
2015 - 2021
13.2.3.5.4.2. Market
Forecast, 2022
– 2030
13.2.3.5.5. Latin America
13.2.3.5.5.1. Market
Estimation,
2015 - 2021
13.2.3.5.5.2. Market
Forecast, 2022
– 2030
13.2.4.
13.2.4.
13.2.4.1. Definition
13.2.4.2. Market
Estimation and Penetration, 2015 - 2021
13.2.4.3. Market
Forecast, 2022
– 2030
13.2.4.4. Compound Annual Growth Rate (CAGR)
13.2.4.5. Regional Bifurcation
13.2.4.5.1. North America
13.2.4.5.1.1. Market
Estimation,
2015 - 2021
13.2.4.5.1.2. Market
Forecast, 2022
– 2030
13.2.4.5.2. Europe
13.2.4.5.2.1. Market
Estimation,
2015 - 2021
13.2.4.5.2.2. Market
Forecast, 2022
– 2030
13.2.4.5.3. Asia Pacific
13.2.4.5.3.1. Market
Estimation,
2015 - 2021
13.2.4.5.3.2.
Market Forecast,
2022 – 2030 13.2.4.5.4. Middle East and Africa
13.2.4.5.4.1. Market
Estimation,
2015 - 2021
13.2.4.5.4.2. Market
Forecast, 2022
– 2030
13.2.4.5.5. Latin America
13.2.4.5.5.1. Market
Estimation,
2015 - 2021
13.2.4.5.5.2. Market
Forecast, 2022
– 2030
13.3. Key Segment for
Channeling Investments
13.3.1.
By Application
14. Global
Clinical Chemistry Analyzer Market
Analysis and Forecasts, 2022 – 2030
14.1.
Overview
14.2.
Global
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
14.2.1.
Physician
Office Laboratory
14.2.1.1. Definition
14.2.1.2. Market
Estimation and Penetration, 2015 - 2021
14.2.1.3. Market
Forecast, 2022
– 2030
14.2.1.4. Compound Annual Growth Rate (CAGR)
14.2.1.5. Regional Bifurcation
14.2.1.5.1. North America
14.2.1.5.1.1. Market
Estimation,
2015 - 2021
14.2.1.5.1.2. Market
Forecast, 2022
– 2030
14.2.1.5.2. Europe
14.2.1.5.2.1. Market
Estimation,
2015 - 2021
14.2.1.5.2.2. Market
Forecast, 2022
– 2030
14.2.1.5.3. Asia Pacific
14.2.1.5.3.1. Market
Estimation,
2015 - 2021
14.2.1.5.3.2.
Market Forecast,
2022 – 2030 14.2.1.5.4. Middle East and Africa
14.2.1.5.4.1. Market
Estimation,
2015 - 2021
14.2.1.5.4.2. Market
Forecast, 2022
– 2030
14.2.1.5.5. Latin America
14.2.1.5.5.1. Market
Estimation,
2015 - 2021
14.2.1.5.5.2. Market
Forecast, 2022
– 2030
14.2.2.
Hospital Laboratory
14.2.2.1. Definition
14.2.2.2. Market
Estimation and Penetration, 2015 - 2021
14.2.2.3. Market
Forecast, 2022
– 2030
14.2.2.4. Compound Annual Growth Rate (CAGR)
14.2.2.5. Regional Bifurcation
14.2.2.5.1. North America
14.2.2.5.1.1. Market
Estimation,
2015 - 2021
14.2.2.5.1.2. Market
Forecast, 2022
– 2030
14.2.2.5.2. Europe
14.2.2.5.2.1. Market
Estimation,
2015 - 2021
14.2.2.5.2.2. Market
Forecast, 2022
– 2030
14.2.2.5.3. Asia Pacific
14.2.2.5.3.1. Market
Estimation,
2015 - 2021
14.2.2.5.3.2.
Market Forecast,
2022 – 2030 14.2.2.5.4. Middle East and Africa
14.2.2.5.4.1. Market
Estimation,
2015 - 2021
14.2.2.5.4.2. Market
Forecast, 2022
– 2030
14.2.2.5.5. Latin America
14.2.2.5.5.1. Market
Estimation,
2015 - 2021
14.2.2.5.5.2. Market
Forecast, 2022
– 2030
14.2.3.
Point-of-care clinics
14.2.3.1. Definition
14.2.3.2. Market
Estimation and Penetration, 2015 - 2021
14.2.3.3. Market
Forecast, 2022
– 2030
14.2.3.4. Compound Annual Growth Rate (CAGR)
14.2.3.5. Regional Bifurcation
14.2.3.5.1. North America
14.2.3.5.1.1. Market
Estimation,
2015 - 2021
14.2.3.5.1.2. Market
Forecast, 2022
– 2030
14.2.3.5.2. Europe
14.2.3.5.2.1. Market
Estimation,
2015 - 2021
14.2.3.5.2.2. Market
Forecast, 2022
– 2030
14.2.3.5.3. Asia Pacific
14.2.3.5.3.1. Market
Estimation,
2015 - 2021
14.2.3.5.3.2.
Market Forecast,
2022 – 2030 14.2.3.5.4. Middle East and Africa
14.2.3.5.4.1. Market
Estimation,
2015 - 2021
14.2.3.5.4.2. Market
Forecast, 2022
– 2030
14.2.3.5.5. Latin America
14.2.3.5.5.1. Market
Estimation,
2015 - 2021
14.2.3.5.5.2. Market
Forecast, 2022
– 2030
14.2.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine
Laboratories
14.2.4.1. Definition
14.2.4.2. Market
Estimation and Penetration, 2015 - 2021
14.2.4.3. Market
Forecast, 2022
– 2030
14.2.4.4. Compound Annual Growth Rate (CAGR)
14.2.4.5. Regional Bifurcation
14.2.4.5.1. North America
14.2.4.5.1.1. Market
Estimation,
2015 - 2021
14.2.4.5.1.2. Market
Forecast, 2022
– 2030
14.2.4.5.2. Europe
14.2.4.5.2.1. Market
Estimation,
2015 - 2021
14.2.4.5.2.2. Market
Forecast, 2022
– 2030
14.2.4.5.3. Asia Pacific
14.2.4.5.3.1. Market
Estimation,
2015 - 2021
14.2.4.5.3.2.
Market Forecast,
2022 – 2030 14.2.4.5.4. Middle East and Africa
14.2.4.5.4.1. Market
Estimation,
2015 - 2021
14.2.4.5.4.2. Market
Forecast, 2022
– 2030
14.2.4.5.5.
Latin America
14.2.5.
Core Laboratory
14.2.5.1. Definition
14.2.4.5.5.1. Market
Estimation,
2015 - 2021
14.2.4.5.5.2. Market
Forecast, 2022
– 2030
14.2.5.2. Market
Estimation and Penetration, 2015 - 2021
14.2.5.3. Market
Forecast, 2022
– 2030
14.2.5.4. Compound Annual Growth Rate (CAGR)
14.2.5.5. Regional Bifurcation
14.2.5.5.1. North America
14.2.5.5.1.1. Market
Estimation,
2015 - 2021
14.2.5.5.1.2. Market
Forecast, 2022
– 2030
14.2.5.5.2. Europe
14.2.5.5.2.1. Market
Estimation,
2015 - 2021
14.2.5.5.2.2. Market
Forecast, 2022
– 2030
14.2.5.5.3. Asia Pacific
14.2.5.5.3.1. Market
Estimation,
2015 - 2021
14.2.5.5.3.2.
Market Forecast,
2022 – 2030 14.2.5.5.4. Middle East and Africa
14.2.5.5.4.1. Market
Estimation,
2015 - 2021
14.2.5.5.4.2. Market
Forecast, 2022
– 2030
14.2.5.5.5. Latin America
14.2.5.5.5.1. Market
Estimation, 2015
- 2021
14.2.5.5.5.2. Market
Forecast, 2022
– 2030
14.2.6.
Reference Laboratory
14.2.6.1. Definition
14.2.6.2. Market
Estimation and Penetration, 2015 - 2021
14.2.6.3. Market
Forecast, 2022
– 2030
14.2.6.4. Compound Annual Growth Rate (CAGR)
14.2.6.5. Regional Bifurcation
14.2.6.5.1. North America
14.2.6.5.1.1. Market
Estimation,
2015 - 2021
14.2.6.5.1.2. Market
Forecast, 2022
– 2030
14.2.6.5.2. Europe
14.2.6.5.2.1. Market
Estimation,
2015 - 2021
14.2.6.5.2.2. Market
Forecast, 2022
– 2030
14.2.6.5.3. Asia Pacific
14.2.6.5.3.1. Market
Estimation,
2015 - 2021
14.2.6.5.3.2.
Market Forecast,
2022 – 2030 14.2.6.5.4. Middle East and Africa
14.2.6.5.4.1. Market
Estimation,
2015 - 2021
14.2.6.5.4.2. Market
Forecast, 2022
– 2030
14.2.6.5.5. Latin America
14.2.6.5.5.1. Market
Estimation,
2015 - 2021
14.2.6.5.5.2. Market
Forecast, 2022
– 2030
14.2.7.
Integrated
Delivery Network
14.2.7.1. Definition
14.2.7.2. Market
Estimation and Penetration, 2015 - 2021
14.2.7.3. Market
Forecast, 2022
– 2030
14.2.7.4. Compound Annual Growth Rate (CAGR)
14.2.7.5. Regional Bifurcation
14.2.7.5.1. North America
14.2.7.5.1.1. Market
Estimation,
2015 - 2021
14.2.7.5.1.2. Market
Forecast, 2022
– 2030
14.2.7.5.2. Europe
14.2.7.5.2.1. Market
Estimation,
2015 - 2021
14.2.7.5.2.2. Market
Forecast, 2022
– 2030
14.2.7.5.3. Asia Pacific
14.2.7.5.3.1. Market
Estimation,
2015 - 2021
14.2.7.5.3.2.
Market Forecast,
2022 – 2030 14.2.7.5.4. Middle East and Africa
14.2.7.5.4.1. Market
Estimation,
2015 - 2021
14.2.7.5.4.2. Market
Forecast, 2022
– 2030
14.2.7.5.5. Latin America
14.2.7.5.5.1. Market
Estimation,
2015 - 2021
14.2.7.5.5.2. Market
Forecast, 2022
– 2030
14.2.8.
Others
14.2.8.1. Definition
14.2.8.2. Market
Estimation and Penetration, 2015 - 2021
14.2.8.3. Market
Forecast, 2022
– 2030
14.2.8.4. Compound Annual Growth Rate (CAGR)
14.2.8.5. Regional Bifurcation
14.2.8.5.1. North America
14.2.8.5.1.1. Market
Estimation,
2015 - 2021
14.2.8.5.1.2. Market
Forecast, 2022
– 2030
14.2.8.5.2. Europe
14.2.8.5.2.1. Market
Estimation,
2015 - 2021
14.2.8.5.2.2. Market
Forecast, 2022
– 2030
14.2.8.5.3. Asia Pacific
14.2.8.5.3.1. Market
Estimation,
2015 - 2021
14.2.8.5.3.2.
Market Forecast,
2022 – 2030 14.2.8.5.4. Middle East and Africa
14.2.8.5.4.1. Market
Estimation,
2015 - 2021
14.2.8.5.4.2. Market
Forecast, 2022
– 2030
14.2.8.5.5. Latin America
14.2.8.5.5.1. Market
Estimation,
2015 - 2021
14.2.8.5.5.2. Market
Forecast, 2022
– 2030
14.3. Key Segment for Channeling Investments
14.3.1.
By
End User
15. North
America Clinical Chemistry Analyzer
Market Analysis and Forecasts, 2022
– 2030
15.1.
Overview
15.1.1.
North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn)
15.2. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement Technologies
15.2.1.
Photometric
and colorimetric testing
15.2.2.
Ion-selective potentiometry
15.2.3.
Latex agglutination
15.2.4.
Others
15.3. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Type
15.3.1.
Automated
15.3.2.
Benchtop Analyzer
15.3.3.
Others
15.4. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
15.4.1.
Serum
15.4.2.
Plasma
15.4.3.
Urine
15.4.4.
Other
body fluids
15.5. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
15.5.1.
400/800
with ISE
15.5.2.
800/1,200 with ISE
15.5.3. Up to 8,000 test/hour
15.5.4. Up to 9,800 test/hour with dual
ISE
15.5.5. Others
15.6. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
15.6.1.
80
(8 racks x 10 samples), 22 samples by carousel
15.6.2.
150
(15 racks x 10 samples), 22 samples
by carousel
15.6.3.
400
samples (2 x 20 rack set)
15.6.4.
Others
15.7. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.1.
Diabetes
15.7.2.
Testing
for metabolic functions or cardiac markers
15.7.3. Drugs-of-abuse testing
15.7.4.
15.8. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By End User
15.8.1.
Physician
Office Laboratory
15.8.2.
Hospital Laboratory
15.8.3.
Point-of-care clinics
15.8.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine
Laboratories
15.8.5.
Core Laboratory
15.8.6.
Reference Laboratory
15.8.7.
Integrated
Delivery Network
15.8.8.
Others
15.9. North America Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Country
15.9.1.
U.S
15.9.1.1.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
15.9.1.1.1.
Photometric and colorimetric
testing 15.9.1.1.2. Ion-selective potentiometry
15.9.1.1.3. Latex agglutination
15.9.1.1.4. Others
15.9.1.2.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
15.9.1.2.1. Automated
15.9.1.2.2. Benchtop Analyzer
15.9.1.2.3. Others
15.9.1.3.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
15.9.1.3.1. Serum
15.9.1.3.2. Plasma
15.9.1.3.3. Urine
15.9.1.3.4. Other body fluids
15.9.1.4.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
15.9.1.4.1. 400/800 with ISE
15.9.1.4.2. 800/1,200
with ISE
15.9.1.4.3. Up to 8,000 test/hour
15.9.1.4.4.
Up to 9,800 test/hour with dual ISE 15.9.1.4.5. Others
15.9.1.5.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
15.9.1.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
15.9.1.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
15.9.1.5.3. 400 samples (2 x 20 rack set)
15.9.1.5.4. Others
15.9.1.6.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
15.9.1.6.1. Diabetes
15.9.1.6.2.
Testing for metabolic
functions or cardiac markers
15.9.1.6.3. Drugs-of-abuse testing
15.9.1.6.4.
15.9.1.7.
U.S Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
15.9.1.7.1.
Physician Office Laboratory
15.9.1.7.2. Hospital Laboratory
15.9.1.7.3. Point-of-care clinics
15.9.1.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
15.9.1.7.5. Core Laboratory
15.9.1.7.6.
Reference Laboratory 15.9.1.7.7. Integrated Delivery Network 15.9.1.7.8. Others
15.9.2.
Canada
15.9.2.1.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
15.9.2.1.1.
Photometric and colorimetric
testing 15.9.2.1.2. Ion-selective potentiometry
15.9.2.1.3. Latex agglutination
15.9.2.1.4. Others
15.9.2.2.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
15.9.2.2.1. Automated
15.9.2.2.2. Benchtop Analyzer
15.9.2.2.3. Others
15.9.2.3.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
15.9.2.3.1. Serum
15.9.2.3.2. Plasma
15.9.2.3.3. Urine
15.9.2.3.4. Other body fluids
15.9.2.4.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
15.9.2.4.1. 400/800 with ISE
15.9.2.4.2.
800/1,200 with ISE
15.9.2.4.3. Up to 8,000 test/hour
15.9.2.4.4.
Up to 9,800 test/hour with dual ISE 15.9.2.4.5. Others
15.9.2.5.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
15.9.2.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
15.9.2.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
15.9.2.5.3. 400 samples (2 x 20 rack
set)
15.9.2.5.4. Others
15.9.2.6.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
15.9.2.6.1. Diabetes
15.9.2.6.2.
Testing for metabolic
functions or cardiac markers
15.9.2.6.3. Drugs-of-abuse testing
15.9.2.6.4.
15.9.2.7.
Canada Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
15.9.2.7.1. Physician Office Laboratory
15.9.3.
Mexico
15.9.3.1.1.
Hospital Laboratory
15.9.3.1.2.
Point-of-care clinics
15.9.3.1.3.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
15.9.3.1.4.
Core Laboratory
15.9.3.1.5.
Reference Laboratory 15.9.2.7.7. Integrated Delivery Network 15.9.2.7.8. Others
15.9.3.2.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement Technologies
15.9.3.2.1.
Photometric and colorimetric
testing 15.9.3.1.2. Ion-selective potentiometry
15.9.3.1.3. Latex agglutination
15.9.3.1.4. Others
15.9.3.3.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Type
15.9.3.3.1. Automated
15.9.3.3.2. Benchtop Analyzer
15.9.3.3.3. Others
15.9.3.4.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
15.9.3.4.1. Serum
15.9.3.4.2. Plasma
15.9.3.4.3. Urine
15.9.3.4.4. Other body fluids
15.9.3.5.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
15.9.3.5.1. 400/800 with ISE
15.9.3.4.2.
800/1,200 with ISE
15.9.3.4.3. Up to 8,000 test/hour
15.9.3.4.4.
Up to 9,800 test/hour with dual ISE 15.9.3.4.5. Others
15.9.3.6.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
15.9.3.6.1. 80 (8 racks x 10 samples), 22 samples
by carousel
15.9.3.6.2. 150 (15 racks x 10 samples),
22 samples by carousel
15.9.3.6.3. 400 samples (2 x 20 rack set)
15.9.3.6.4. Others
15.9.3.7.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
15.9.3.7.1. Diabetes
15.9.3.7.2.
Testing for metabolic
functions or cardiac markers
15.9.3.6.3. Drugs-of-abuse testing
15.9.3.6.4.
15.9.3.8.
Mexico Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By End User
15.9.3.8.1.
Physician Office Laboratory
15.9.3.7.2. Hospital Laboratory
15.9.3.7.3. Point-of-care clinics
15.9.3.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
15.9.3.7.5. Core Laboratory
15.9.3.7.6.
Reference Laboratory 15.9.3.7.7. Integrated Delivery Network 15.9.3.7.8. Others
15.9.4. Rest of North America
15.9.4.1.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Measurement Technologies
15.9.4.1.1.
Photometric and colorimetric
testing 15.9.4.1.2. Ion-selective potentiometry
15.9.4.1.3. Latex agglutination
15.9.4.1.4. Others
15.9.4.2.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
15.9.4.2.1. Automated
15.9.4.2.2. Benchtop Analyzer
15.9.4.2.3. Others
15.9.4.3.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
15.9.4.3.1. Serum
15.9.4.3.2. Plasma
15.9.4.3.3. Urine
15.9.4.3.4. Other body fluids
15.9.4.4.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Photometric Throughput
15.9.4.4.1. 400/800 with ISE
15.9.4.4.2.
800/1,200 with ISE
15.9.4.4.3. Up to 8,000 test/hour
15.9.4.4.4.
Up to 9,800 test/hour with dual ISE 15.9.4.4.5. Others
15.9.4.5.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Sample Load Capacity
15.9.4.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
15.9.4.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
15.9.4.5.3. 400 samples (2 x 20 rack
set)
15.9.4.5.4. Others
15.9.4.6.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
15.9.4.6.1. Diabetes
15.9.4.6.2.
Testing for metabolic
functions or cardiac markers
15.9.4.6.3. Drugs-of-abuse testing
15.9.4.6.4.
15.9.4.7.
Rest of North
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
End User
15.9.4.7.1.
Physician Office Laboratory
15.9.4.7.2. Hospital Laboratory
15.9.4.7.3. Point-of-care clinics
15.9.4.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
15.9.4.7.5. Core Laboratory
15.9.4.7.6.
Reference Laboratory 15.9.4.7.7. Integrated Delivery Network 15.9.4.7.8. Others
15.10. Key Segment for
Channeling Investments
15.10.1.
By Country
15.10.2.
By
Measurement Technologies
15.10.3. By Type
15.10.4.
By Substances
15.10.5.
By
Photometric Throughput
15.10.6.
By
Sample Load Capacity
15.10.7.
By Application
15.10.8.
By
End User
16. Europe
Clinical Chemistry Analyzer Market Analysis and Forecasts, 2022 – 2030
16.1.
Overview
16.1.1.
Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn)
16.2. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By Measurement Technologies
16.2.1.
Photometric
and colorimetric testing
16.2.2.
Ion-selective potentiometry
16.2.3. Latex agglutination
16.2.4.
Others
16.3.
Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
16.3.1.
Automated
16.3.2.
Benchtop Analyzer
16.3.3.
Others
16.4. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By Substances
16.4.1.
Serum
16.4.2.
Plasma
16.4.3.
Urine
16.4.4.
Other
body fluids
16.5. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By Photometric Throughput
16.5.1.
400/800
with ISE
16.5.2.
800/1,200 with ISE
16.5.3. Up to 8,000 test/hour
16.5.4. Up to 9,800 test/hour with dual
ISE
16.5.5. Others
16.6. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By Sample Load Capacity
16.6.1.
80
(8 racks x 10 samples), 22 samples by carousel
16.6.2.
150
(15 racks x 10 samples), 22 samples
by carousel
16.6.3.
400
samples (2 x 20 rack set)
16.6.4.
Others
16.7. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.1.
Diabetes
16.7.2.
Testing
for metabolic functions or cardiac markers
16.7.3. Drugs-of-abuse testing
16.7.4.
16.8. Europe Clinical Chemistry
Analyzer Market Revenue (US$ Mn) and Forecasts,
By End User
16.8.1.
Physician
Office Laboratory
16.8.2.
Hospital Laboratory
16.8.3.
Point-of-care clinics
16.8.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine Laboratories
16.8.5.
Core Laboratory
16.8.6.
Reference Laboratory
16.8.7.
Integrated
Delivery Network
16.8.8.
Others
16.9.
Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Country
16.9.1.
France
16.9.1.1.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
16.9.1.1.1.
Photometric and colorimetric
testing 16.9.1.1.2. Ion-selective potentiometry
16.9.1.1.3. Latex agglutination
16.9.1.1.4. Others
16.9.1.2.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
16.9.1.2.1. Automated
16.9.1.2.2. Benchtop Analyzer
16.9.1.2.3. Others
16.9.1.3.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
16.9.1.3.1. Serum
16.9.1.3.2. Plasma
16.9.1.3.3. Urine
16.9.1.3.4. Other body fluids
16.9.1.4.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
16.9.1.4.1. 400/800 with ISE
16.9.1.4.2.
800/1,200 with ISE
16.9.1.4.3. Up to 8,000 test/hour
16.9.1.4.4.
Up to 9,800 test/hour with dual ISE 16.9.1.4.5. Others
16.9.1.5.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
16.9.1.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.1.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.1.5.3. 400 samples (2 x 20 rack
set)
16.9.1.5.4. Others
16.9.1.6.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
16.9.1.6.1. Diabetes
16.9.1.6.2.
Testing for metabolic
functions or cardiac markers
16.9.1.6.3. Drugs-of-abuse testing
16.9.1.6.4.
16.9.1.7.
France Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
16.9.1.7.1.
Physician Office Laboratory
16.9.1.7.2. Hospital Laboratory
16.9.1.7.3. Point-of-care clinics
16.9.1.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.1.7.5. Core Laboratory
16.9.1.7.6.
Reference Laboratory 16.9.1.7.7. Integrated Delivery Network 16.9.1.7.8. Others
16.9.2. The UK
16.9.2.1.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Measurement
Technologies
16.9.2.1.1.
Photometric and colorimetric
testing 16.9.2.1.2. Ion-selective potentiometry
16.9.2.1.3. Latex agglutination
16.9.2.1.4. Others
16.9.2.2.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.2.2.1. Automated
16.9.2.2.2. Benchtop Analyzer
16.9.2.2.3. Others
16.9.2.3.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Substances
16.9.2.3.1. Serum
16.9.2.3.2. Plasma
16.9.2.3.3. Urine
16.9.2.3.4. Other body fluids
16.9.2.4.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Photometric Throughput
16.9.2.4.1. 400/800 with ISE
16.9.2.4.2.
800/1,200 with ISE
16.9.2.4.3. Up to 8,000 test/hour
16.9.2.4.4.
Up to 9,800 test/hour with dual ISE 16.9.2.4.5. Others
16.9.2.5.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Sample
Load Capacity
16.9.2.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.2.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.2.5.3. 400 samples (2 x 20 rack
set)
16.9.2.5.4. Others
16.9.2.6.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Application
16.9.2.6.1. Diabetes
16.9.2.6.2.
Testing for metabolic
functions or cardiac markers 16.9.2.6.3.
Drugs-of-abuse testing
16.9.2.6.4.
16.9.2.7.
The UK Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By End User
16.9.2.7.1.
Physician Office Laboratory
16.9.2.7.2. Hospital Laboratory
16.9.2.7.3. Point-of-care clinics
16.9.2.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.2.7.5. Core Laboratory
16.9.2.7.6.
Reference Laboratory 16.9.2.7.7. Integrated Delivery Network 16.9.2.7.8. Others
16.9.3. Spain
16.9.3.1.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
16.9.3.1.1.
Photometric and colorimetric
testing 16.9.3.1.2. Ion-selective potentiometry
16.9.3.1.3. Latex agglutination
16.9.3.1.4. Others
16.9.3.2.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
16.9.3.2.1. Automated
16.9.3.2.2. Benchtop Analyzer
16.9.3.2.3. Others
16.9.3.3.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
16.9.3.3.1. Serum
16.9.3.3.2. Plasma
16.9.3.3.3. Urine
16.9.3.3.4. Other body fluids
16.9.3.4.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
16.9.3.4.1. 400/800 with ISE
16.9.3.4.2.
800/1,200 with ISE
16.9.3.4.3. Up to 8,000 test/hour
16.9.3.4.4.
Up to 9,800 test/hour with dual ISE 16.9.3.4.5. Others
16.9.3.5.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
16.9.3.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.3.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.3.5.3. 400 samples (2 x 20 rack
set)
16.9.3.5.4. Others
16.9.3.6.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
16.9.3.6.1. Diabetes
16.9.3.6.2.
Testing for metabolic
functions or cardiac markers
16.9.3.6.3. Drugs-of-abuse testing
16.9.3.6.4.
16.9.3.7.
Spain Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
16.9.3.7.1.
Physician Office Laboratory
16.9.3.7.2. Hospital Laboratory
16.9.3.7.3. Point-of-care clinics
16.9.3.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.3.7.5. Core Laboratory
16.9.3.7.6.
Reference Laboratory 16.9.3.7.7. Integrated Delivery
Network
16.9.3.7.8.
Others
16.9.4.
Germany
16.9.4.1.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Measurement Technologies
16.9.4.1.1.
Photometric and colorimetric
testing 16.9.4.1.2. Ion-selective potentiometry
16.9.4.1.3. Latex agglutination
16.9.4.1.4. Others
16.9.4.2.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Type
16.9.4.2.1. Automated
16.9.4.2.2. Benchtop Analyzer
16.9.4.2.3. Others
16.9.4.3.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Substances
16.9.4.3.1. Serum
16.9.4.3.2. Plasma
16.9.4.3.3. Urine
16.9.4.3.4. Other body fluids
16.9.4.4.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Photometric Throughput
16.9.4.4.1. 400/800 with ISE
16.9.4.4.2.
800/1,200 with ISE
16.9.4.4.3. Up to 8,000 test/hour
16.9.4.4.4.
Up to 9,800 test/hour with dual ISE 16.9.4.4.5. Others
16.9.4.5.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Sample
Load Capacity
16.9.4.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.4.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.4.5.3. 400 samples (2 x 20 rack set)
16.9.4.5.4. Others
16.9.4.6.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Application
16.9.4.6.1. Diabetes
16.9.4.6.2.
Testing for metabolic
functions or cardiac markers
16.9.4.6.3. Drugs-of-abuse testing
16.9.4.6.4.
16.9.4.7.
Germany Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By End User
16.9.4.7.1.
Physician Office Laboratory
16.9.4.7.2. Hospital Laboratory
16.9.4.7.3. Point-of-care clinics
16.9.4.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.4.7.5. Core Laboratory
16.9.4.7.6.
Reference Laboratory 16.9.4.7.7. Integrated Delivery Network 16.9.4.7.8. Others
16.9.5. Italy
16.9.5.1.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement
Technologies
16.9.5.1.1.
Photometric and colorimetric
testing 16.9.5.1.2. Ion-selective potentiometry
16.9.5.1.3. Latex agglutination
16.9.5.1.4. Others
16.9.5.2.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Type
16.9.5.2.1. Automated
16.9.5.2.2. Benchtop Analyzer
16.9.5.2.3. Others
16.9.5.3.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
16.9.5.3.1. Serum
16.9.5.3.2. Plasma
16.9.5.3.3. Urine
16.9.5.3.4. Other body fluids
16.9.5.4.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
16.9.5.4.1. 400/800 with ISE
16.9.5.4.2.
800/1,200 with ISE
16.9.5.4.3. Up to 8,000 test/hour
16.9.5.4.4.
Up to 9,800 test/hour with dual ISE 16.9.5.4.5. Others
16.9.5.5.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
16.9.5.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.5.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.5.5.3. 400 samples (2 x 20 rack
set)
16.9.5.5.4. Others
16.9.5.6.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
16.9.5.6.1. Diabetes
16.9.5.6.2.
Testing for metabolic
functions or cardiac markers
16.9.5.6.3. Drugs-of-abuse testing
16.9.5.6.4.
16.9.5.7.
Italy Clinical Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By End User
16.9.5.7.1.
Physician Office Laboratory
16.9.5.7.2. Hospital Laboratory
16.9.5.7.3. Point-of-care clinics
16.9.5.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.5.7.5. Core Laboratory
16.9.5.7.6.
Reference Laboratory 16.9.5.7.7. Integrated Delivery Network 16.9.5.7.8. Others
16.9.6. Nordic Countries
16.9.6.1.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Measurement Technologies
16.9.6.1.1.
Photometric and colorimetric
testing 16.9.6.1.2. Ion-selective potentiometry
16.9.6.1.3. Latex agglutination
16.9.6.1.4. Others
16.9.6.2.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
16.9.6.2.1. Automated
16.9.6.2.2. Benchtop Analyzer
16.9.6.2.3. Others
16.9.6.3.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Substances
16.9.6.3.1. Serum
16.9.6.3.2. Plasma
16.9.6.3.3. Urine
16.9.6.3.4. Other body fluids
16.9.6.4.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Photometric Throughput
16.9.6.4.1. 400/800 with ISE
16.9.6.4.2.
800/1,200 with ISE
16.9.6.4.3. Up to 8,000 test/hour
16.9.6.4.4.
Up to 9,800 test/hour with dual ISE 16.9.6.4.5. Others
16.9.6.5.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Sample Load Capacity
16.9.6.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.6.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.6.5.3. 400 samples (2 x 20 rack
set)
16.9.6.5.4. Others
16.9.6.6.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Application
16.9.6.6.1. Diabetes
16.9.6.6.2.
Testing for metabolic
functions or cardiac markers
16.9.6.6.3. Drugs-of-abuse testing
16.9.6.6.4.
16.9.6.7.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
End User
16.9.6.7.1.
Physician Office Laboratory
16.9.6.7.2. Hospital Laboratory
16.9.6.7.3. Point-of-care clinics
16.9.6.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.6.7.5. Core Laboratory
16.9.6.7.6.
Reference Laboratory 16.9.6.7.7. Integrated Delivery Network 16.9.6.7.8. Others
16.9.6.8.
Nordic Countries Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Country
16.9.6.8.1. Denmark
16.9.6.8.2. Finland
16.9.6.8.3. Iceland
16.9.6.8.4. Sweden
16.9.6.8.5. Norway
16.9.7.
Benelux Union
16.9.7.1.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By
Measurement Technologies
16.9.7.1.1.
Photometric and colorimetric
testing 16.9.7.1.2. Ion-selective potentiometry
16.9.7.1.3. Latex agglutination
16.9.7.1.4. Others
16.9.7.2.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Type
16.9.7.2.1. Automated
16.9.7.2.2. Benchtop Analyzer
16.9.7.2.3. Others
16.9.7.3.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Substances
16.9.7.3.1. Serum
16.9.7.3.2. Plasma
16.9.7.3.3. Urine
16.9.7.3.4. Other body fluids
16.9.7.4.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By
Photometric Throughput
16.9.7.4.1. 400/800 with ISE
16.9.7.4.2.
800/1,200 with ISE
16.9.7.4.3. Up to 8,000 test/hour
16.9.7.4.4.
Up to 9,800 test/hour with dual ISE 16.9.7.4.5. Others
16.9.7.5.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By
Sample Load Capacity
16.9.7.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.7.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.7.5.3. 400 samples (2 x 20 rack
set)
16.9.7.5.4. Others
16.9.7.6.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Application
16.9.7.6.1. Diabetes
16.9.7.6.2.
Testing for metabolic
functions or cardiac markers
16.9.7.6.3. Drugs-of-abuse testing
16.9.7.6.4.
16.9.7.7.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By
End User
16.9.7.7.1. Physician Office Laboratory
16.9.7.7.2. Hospital Laboratory
16.9.7.7.3. Point-of-care clinics
16.9.7.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.7.7.5. Core Laboratory
16.9.7.7.6.
Reference Laboratory 16.9.7.7.7. Integrated Delivery Network 16.9.7.7.8. Others
16.9.7.8.
Benelux Union Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Country
16.9.7.8.1. Belgium
16.9.7.8.2. The Netherlands
16.9.7.8.3. Luxembourg
16.9.8.
Rest
of
Europe
16.9.8.1.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
16.9.8.1.1.
Photometric and colorimetric
testing 16.9.8.1.2. Ion-selective potentiometry
16.9.8.1.3. Latex agglutination
16.9.8.1.4. Others
16.9.8.2.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
16.9.8.2.1. Automated
16.9.8.2.2. Benchtop Analyzer
16.9.8.2.3. Others
16.9.8.3.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
16.9.8.3.1. Serum
16.9.8.3.2. Plasma
16.9.8.3.3. Urine
16.9.8.3.4. Other body fluids
16.9.8.4.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
16.9.8.4.1. 400/800 with ISE
16.9.8.4.2.
800/1,200 with ISE
16.9.8.4.3. Up to 8,000 test/hour
16.9.8.4.4.
Up to 9,800 test/hour with dual ISE 16.9.8.4.5. Others
16.9.8.5.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
16.9.8.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
16.9.8.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
16.9.8.5.3. 400 samples (2 x 20 rack
set)
16.9.8.5.4. Others
16.9.8.6.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
16.9.8.6.1. Diabetes
16.9.8.6.2.
Testing for metabolic
functions or cardiac markers
16.9.8.6.3. Drugs-of-abuse testing
16.9.8.6.4.
16.9.8.7.
Rest of Europe
Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
16.9.8.7.1.
Physician Office Laboratory
16.9.8.7.2. Hospital Laboratory
16.9.8.7.3. Point-of-care clinics
16.9.8.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
16.9.8.7.5. Core Laboratory
16.9.8.7.6.
Reference Laboratory 16.9.8.7.7. Integrated Delivery Network 16.9.8.7.8. Others
16.10. Key Segment for
Channeling Investments
16.10.1. By Country
16.10.2.
By
Measurement Technologies
16.10.3.
By Type
16.10.4.
By Substances
16.10.5.
By
Photometric Throughput
16.10.6.
By
Sample Load Capacity
16.10.7.
By Application
16.10.8.
By
End User
17. Asia
Pacific Clinical Chemistry Analyzer Market Analysis and Forecasts, 2022 – 2030
17.1.
Overview
17.1.1.
Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn)
17.2. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement Technologies
17.2.1.
Photometric
and colorimetric testing
17.2.2.
Ion-selective potentiometry
17.2.3.
Latex agglutination
17.2.4.
Others
17.3. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Type
17.3.1.
Automated
17.3.2.
Benchtop Analyzer
17.3.3.
Others
17.4. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
17.4.1.
Serum
17.4.2.
Plasma
17.4.3.
Urine
17.4.4.
Other
body fluids
17.5. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
17.5.1.
400/800
with ISE
17.5.2.
800/1,200 with ISE
17.5.3. Up to 8,000 test/hour
17.5.4. Up to 9,800 test/hour with dual
ISE
17.5.5. Others
17.6. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
17.6.1.
80
(8 racks x 10 samples), 22 samples by carousel
17.6.2.
150
(15 racks x 10 samples), 22 samples
by carousel
17.6.3.
400
samples (2 x 20 rack set)
17.6.4.
Others
17.7. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.1.
Diabetes
17.7.2.
Testing
for metabolic functions or cardiac markers
17.7.3. Drugs-of-abuse testing
17.7.4.
17.8. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By End User
17.8.1.
Physician
Office Laboratory
17.8.2.
Hospital Laboratory
17.8.3.
Point-of-care clinics
17.8.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine
Laboratories
17.8.5.
Core Laboratory
17.8.6.
Reference Laboratory
17.8.7.
Integrated
Delivery Network
17.8.8.
Others
17.9. Asia Pacific Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Country
17.9.1.
China
17.9.1.1.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
17.9.1.1.1.
Photometric and colorimetric
testing 17.9.1.1.2. Ion-selective potentiometry
17.9.1.1.3. Latex agglutination
17.9.1.1.4. Others
17.9.1.2.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
17.9.1.2.1. Automated
17.9.1.2.2. Benchtop Analyzer
17.9.1.2.3. Others
17.9.1.3.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
17.9.1.3.1. Serum
17.9.1.3.2. Plasma
17.9.1.3.3. Urine
17.9.1.3.4. Other body fluids
17.9.1.4.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
17.9.1.4.1. 400/800 with ISE
17.9.1.4.2.
800/1,200 with ISE
17.9.1.4.3. Up to 8,000 test/hour
17.9.1.4.4.
Up to 9,800 test/hour with dual ISE 17.9.1.4.5. Others
17.9.1.5.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
17.9.1.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.1.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.1.5.3. 400 samples (2 x 20 rack
set)
17.9.1.5.4. Others
17.9.1.6.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
17.9.1.6.1. Diabetes
17.9.1.6.2.
Testing for metabolic
functions or cardiac markers
17.9.1.6.3. Drugs-of-abuse testing
17.9.1.6.4.
17.9.1.7.
China Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
17.9.1.7.1.
Physician Office Laboratory
17.9.1.7.2. Hospital Laboratory
17.9.1.7.3. Point-of-care clinics
17.9.1.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.1.7.5. Core Laboratory
17.9.1.7.6.
Reference Laboratory 17.9.1.7.7. Integrated Delivery Network 17.9.1.7.8. Others
17.9.2. Japan
17.9.2.1.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
17.9.2.1.1.
Photometric and colorimetric
testing 17.9.2.1.2. Ion-selective potentiometry
17.9.2.1.3. Latex agglutination
17.9.2.1.4. Others
17.9.2.2.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
17.9.2.2.1. Automated
17.9.2.2.2. Benchtop Analyzer
17.9.2.2.3. Others
17.9.2.3.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
17.9.2.3.1. Serum
17.9.2.3.2. Plasma
17.9.2.3.3. Urine
17.9.2.3.4. Other body fluids
17.9.2.4.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
17.9.2.4.1. 400/800 with ISE
17.9.2.4.2.
800/1,200 with ISE
17.9.2.4.3. Up to 8,000 test/hour
17.9.2.4.4.
Up to 9,800 test/hour with dual ISE 17.9.2.4.5. Others
17.9.2.5.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
17.9.2.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.2.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.2.5.3. 400 samples (2 x 20 rack
set)
17.9.2.5.4. Others
17.9.2.6.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
17.9.2.6.1. Diabetes
17.9.2.6.2.
Testing for metabolic
functions or cardiac markers
17.9.2.6.3. Drugs-of-abuse testing
17.9.2.6.4.
17.9.2.7.
Japan Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
17.9.2.7.1.
Physician Office Laboratory
17.9.2.7.2. Hospital Laboratory
17.9.2.7.3. Point-of-care clinics
17.9.2.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.2.7.5. Core Laboratory
17.9.2.7.6.
Reference Laboratory 17.9.2.7.7. Integrated Delivery Network 17.9.2.7.8. Others
17.9.3.
India
17.9.3.1.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
17.9.3.1.1.
Photometric and colorimetric
testing 17.9.3.1.2. Ion-selective potentiometry
17.9.3.1.3. Latex agglutination
17.9.3.1.4. Others
17.9.3.2.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
17.9.3.2.1. Automated
17.9.3.2.2. Benchtop Analyzer
17.9.3.2.3. Others
17.9.3.3.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
17.9.3.3.1. Serum
17.9.3.3.2. Plasma
17.9.3.3.3. Urine
17.9.3.3.4. Other body fluids
17.9.3.4.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
17.9.3.4.1. 400/800 with ISE
17.9.3.4.2.
800/1,200 with ISE
17.9.3.4.3. Up to 8,000 test/hour
17.9.3.4.4.
Up to 9,800 test/hour with dual ISE 17.9.3.4.5. Others
17.9.3.5.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
17.9.3.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.3.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.3.5.3. 400 samples (2 x 20 rack
set)
17.9.3.5.4. Others
17.9.3.6.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
17.9.3.6.1. Diabetes
17.9.3.6.2.
Testing for metabolic
functions or cardiac markers
17.9.3.6.3. Drugs-of-abuse testing
17.9.3.6.4.
17.9.3.7.
India Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
17.9.3.7.1.
Physician Office Laboratory
17.9.3.7.2. Hospital Laboratory
17.9.3.7.3. Point-of-care clinics
17.9.3.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.3.7.5. Core Laboratory
17.9.3.7.6.
Reference Laboratory 17.9.3.7.7. Integrated Delivery Network 17.9.3.7.8. Others
17.9.4. New Zealand
17.9.4.1.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Measurement Technologies
17.9.4.1.1.
Photometric and colorimetric
testing 17.9.4.1.2. Ion-selective potentiometry
17.9.4.1.3. Latex agglutination
17.9.4.1.4. Others
17.9.4.2.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Type
17.9.4.2.1. Automated
17.9.4.2.2. Benchtop Analyzer
17.9.4.2.3. Others
17.9.4.3.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Substances
17.9.4.3.1. Serum
17.9.4.3.2. Plasma
17.9.4.3.3. Urine
17.9.4.3.4. Other body fluids
17.9.4.4.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Photometric Throughput
17.9.4.4.1. 400/800 with ISE
17.9.4.4.2.
800/1,200 with ISE
17.9.4.4.3. Up to 8,000 test/hour
17.9.4.4.4.
Up to 9,800 test/hour with dual ISE 17.9.4.4.5. Others
17.9.4.5.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Sample
Load Capacity
17.9.4.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.4.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.4.5.3. 400 samples (2 x 20 rack set)
17.9.4.5.4. Others
17.9.4.6.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Application
17.9.4.6.1. Diabetes
17.9.4.6.2.
Testing for metabolic
functions or cardiac markers 17.9.4.6.3.
Drugs-of-abuse testing
17.9.4.6.4.
17.9.4.7.
New Zealand Clinical Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By End User
17.9.4.7.1.
Physician Office Laboratory
17.9.4.7.2. Hospital Laboratory
17.9.4.7.3. Point-of-care clinics
17.9.4.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.4.7.5. Core Laboratory
17.9.4.7.6.
Reference Laboratory 17.9.4.7.7. Integrated Delivery Network 17.9.4.7.8. Others
17.9.5.
Australia
17.9.5.1.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
17.9.5.1.1.
Photometric and colorimetric
testing 17.9.5.1.2. Ion-selective potentiometry
17.9.5.1.3. Latex agglutination
17.9.5.1.4. Others
17.9.5.2.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
17.9.5.2.1. Automated
17.9.5.2.2. Benchtop Analyzer
17.9.5.2.3. Others
17.9.5.3.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
17.9.5.3.1. Serum
17.9.5.3.2. Plasma
17.9.5.3.3. Urine
17.9.5.3.4. Other body fluids
17.9.5.4.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
17.9.5.4.1. 400/800 with ISE
17.9.5.4.2.
800/1,200 with ISE
17.9.5.4.3. Up to 8,000 test/hour
17.9.5.4.4.
Up to 9,800 test/hour with dual ISE 17.9.5.4.5. Others
17.9.5.5.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
17.9.5.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.5.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.5.5.3. 400 samples (2 x 20 rack
set)
17.9.5.5.4. Others
17.9.5.6.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
17.9.5.6.1. Diabetes
17.9.5.6.2.
Testing for metabolic
functions or cardiac markers
17.9.5.6.3. Drugs-of-abuse testing
17.9.5.6.4.
17.9.5.7.
Australia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
17.9.5.7.1.
Physician Office Laboratory
17.9.5.7.2. Hospital Laboratory
17.9.5.7.3. Point-of-care clinics
17.9.5.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.5.7.5. Core Laboratory
17.9.5.7.6.
Reference Laboratory 17.9.5.7.7. Integrated Delivery Network 17.9.5.7.8. Others
17.9.6. South
Korea
17.9.6.1.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Measurement Technologies
17.9.6.1.1.
Photometric and colorimetric
testing 17.9.6.1.2. Ion-selective potentiometry
17.9.6.1.3. Latex agglutination
17.9.6.1.4. Others
17.9.6.2.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Type
17.9.6.2.1. Automated
17.9.6.2.2. Benchtop Analyzer
17.9.6.2.3. Others
17.9.6.3.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Substances
17.9.6.3.1. Serum
17.9.6.3.2. Plasma
17.9.6.3.3. Urine
17.9.6.3.4. Other body fluids
17.9.6.4.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Photometric Throughput
17.9.6.4.1. 400/800 with ISE
17.9.6.4.2.
800/1,200 with ISE
17.9.6.4.3. Up to 8,000 test/hour
17.9.6.4.4.
Up to 9,800 test/hour with dual ISE 17.9.6.4.5. Others
17.9.6.5.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Sample Load Capacity
17.9.6.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.6.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.6.5.3. 400 samples (2 x 20 rack
set)
17.9.6.5.4. Others
17.9.6.6.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By Application
17.9.6.6.1. Diabetes
17.9.6.6.2.
Testing for metabolic
functions or cardiac markers
17.9.6.6.3. Drugs-of-abuse testing
17.9.6.6.4.
17.9.6.7.
South Korea Clinical
Chemistry Analyzer Market Revenue (US$ Mn) and
Forecasts, By End User
17.9.6.7.1.
Physician Office Laboratory
17.9.6.7.2. Hospital Laboratory
17.9.6.7.3. Point-of-care clinics
17.9.6.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.6.7.5. Core Laboratory
17.9.6.7.6.
Reference Laboratory 17.9.6.7.7. Integrated Delivery Network 17.9.6.7.8. Others
17.9.7.
Southeast Asia
17.9.7.1.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
17.9.7.1.1.
Photometric and colorimetric
testing 17.9.7.1.2. Ion-selective potentiometry
17.9.7.1.3. Latex agglutination
17.9.7.1.4. Others
17.9.7.2.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
17.9.7.2.1. Automated
17.9.7.2.2. Benchtop Analyzer
17.9.7.2.3. Others
17.9.7.3.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
17.9.7.3.1. Serum
17.9.7.3.2. Plasma
17.9.7.3.3. Urine
17.9.7.3.4. Other body fluids
17.9.7.4.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
17.9.7.4.1. 400/800 with ISE
17.9.7.4.2.
800/1,200 with ISE
17.9.7.4.3. Up to 8,000 test/hour
17.9.7.4.4.
Up to 9,800 test/hour with dual ISE 17.9.7.4.5. Others
17.9.7.5.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
17.9.7.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.7.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.7.5.3. 400 samples (2 x 20 rack set)
17.9.7.5.4. Others
17.9.7.6.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
17.9.7.6.1. Diabetes
17.9.7.6.2.
Testing for metabolic
functions or cardiac markers
17.9.7.6.3. Drugs-of-abuse testing
17.9.7.6.4.
17.9.7.7.
Southeast Asia Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By
End User
17.9.7.7.1.
Physician Office Laboratory
17.9.7.7.2. Hospital Laboratory
17.9.7.7.3. Point-of-care clinics
17.9.7.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.7.7.5. Core Laboratory
17.9.7.7.6.
Reference Laboratory 17.9.7.7.7. Integrated Delivery Network 17.9.7.7.8. Others
17.9.7.8.
Southeast Asia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Country
17.9.7.8.1. Indonesia
17.9.7.8.2. Thailand
17.9.7.8.3. Malaysia
17.9.7.8.4. Singapore
17.9.7.8.5. Rest of Southeast Asia
17.9.8.
Rest
of Asia Pacific
17.9.8.1.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
17.9.8.1.1.
Photometric and colorimetric
testing 17.9.8.1.2. Ion-selective potentiometry
17.9.8.1.3. Latex agglutination
17.9.8.1.4. Others
17.9.8.2.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
17.9.8.2.1. Automated
17.9.8.2.2. Benchtop Analyzer
17.9.8.2.3. Others
17.9.8.3.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
17.9.8.3.1. Serum
17.9.8.3.2. Plasma
17.9.8.3.3. Urine
17.9.8.3.4. Other body fluids
17.9.8.4.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Photometric Throughput
17.9.8.4.1. 400/800 with ISE
17.9.8.4.2.
800/1,200 with ISE
17.9.8.4.3. Up to 8,000 test/hour
17.9.8.4.4.
Up to 9,800 test/hour with dual ISE 17.9.8.4.5. Others
17.9.8.5.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
17.9.8.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
17.9.8.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
17.9.8.5.3. 400 samples (2 x 20 rack
set)
17.9.8.5.4. Others
17.9.8.6.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
17.9.8.6.1. Diabetes
17.9.8.6.2.
Testing for metabolic
functions or cardiac markers
17.9.8.6.3. Drugs-of-abuse testing
17.9.8.6.4.
17.9.8.7.
Rest of Asia
Pacific Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
17.9.8.7.1.
Physician Office Laboratory
17.9.8.7.2. Hospital Laboratory
17.9.8.7.3. Point-of-care clinics
17.9.8.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
17.9.8.7.5. Core Laboratory
17.9.8.7.6.
Reference Laboratory 17.9.8.7.7. Integrated Delivery Network 17.9.8.7.8. Others
17.10. Key Segment for
Channeling Investments
17.10.1.
By Country
17.10.2. By Measurement Technologies
17.10.3. By Type
17.10.4.
By Substances
17.10.5.
By
Photometric Throughput
17.10.6.
By
Sample Load Capacity
17.10.7.
By Application
17.10.8.
By
End User
18. Middle
East and Africa Clinical Chemistry Analyzer Market Analysis and Forecasts, 2022 – 2030
18.1.
Overview
18.1.1.
Middle
East and Africa Clinical Chemistry
Analyzer Market Revenue (US$ Mn)
18.2. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.2.1.
Photometric
and colorimetric testing
18.2.2.
Ion-selective potentiometry
18.2.3.
Latex agglutination
18.2.4.
Others
18.3. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
18.3.1.
Automated
18.3.2.
Benchtop Analyzer
18.3.3.
Others
18.4. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
18.4.1.
Serum
18.4.2.
Plasma
18.4.3.
Urine
18.4.4.
Other
body fluids
18.5. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
18.5.1.
400/800
with ISE
18.5.2.
800/1,200 with ISE
18.5.3. Up to 8,000 test/hour
18.5.4. Up to 9,800 test/hour with dual
ISE
18.5.5. Others
18.6. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
18.6.1.
80
(8 racks x 10 samples), 22 samples by carousel
18.6.2.
150
(15 racks x 10 samples), 22 samples
by carousel
18.6.3.
400
samples (2 x 20 rack set)
18.6.4.
Others
18.7. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
18.7.1.
Diabetes
18.7.2.
Testing
for metabolic functions or cardiac markers
18.7.3. Drugs-of-abuse testing
18.7.4.
18.8. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
18.8.1.
Physician
Office Laboratory
18.8.2.
Hospital Laboratory
18.8.3.
Point-of-care clinics
18.8.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine
Laboratories
18.8.5.
Core Laboratory
18.8.6.
Reference Laboratory
18.8.7.
Integrated
Delivery Network
18.8.8.
Others
18.9. Middle East and Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Country
18.9.1.
Saudi Arabia
18.9.1.1.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.9.1.1.1.
Photometric and colorimetric
testing 18.9.1.1.2. Ion-selective potentiometry
18.9.1.1.3. Latex agglutination
18.9.1.1.4. Others
18.9.1.2.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
18.9.1.2.1. Automated
18.9.1.2.2. Benchtop Analyzer
18.9.1.2.3. Others
18.9.1.3.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
18.9.1.3.1. Serum
18.9.1.3.2. Plasma
18.9.1.3.3. Urine
18.9.1.3.4. Other body fluids
18.9.1.4.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
18.9.1.4.1. 400/800 with ISE
18.9.1.4.2.
800/1,200 with ISE
18.9.1.4.3. Up to 8,000 test/hour
18.9.1.4.4.
Up to 9,800 test/hour with dual ISE 18.9.1.4.5. Others
18.9.1.5.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
18.9.1.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.1.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.1.5.3. 400 samples (2 x 20 rack
set)
18.9.1.5.4. Others
18.9.1.6.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
18.9.1.6.1. Diabetes
18.9.1.6.2.
Testing for metabolic
functions or cardiac markers
18.9.1.6.3. Drugs-of-abuse testing
18.9.1.6.4.
18.9.1.7.
Saudi Arabia Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
18.9.1.7.1. Physician Office Laboratory
18.9.2.
UAE
18.9.2.1.1.
Hospital Laboratory
18.9.2.1.2.
Point-of-care clinics
18.9.2.1.3.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.2.1.4.
Core Laboratory
18.9.2.1.5.
Reference Laboratory 18.9.1.7.7. Integrated Delivery Network 18.9.1.7.8. Others
18.9.2.2.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.9.2.2.1.
Photometric and colorimetric
testing 18.9.2.1.2. Ion-selective potentiometry
18.9.2.1.3. Latex agglutination
18.9.2.1.4. Others
18.9.2.3.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
18.9.2.3.1. Automated
18.9.2.3.2. Benchtop Analyzer
18.9.2.3.3. Others
18.9.2.4.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
18.9.2.4.1. Serum
18.9.2.4.2. Plasma
18.9.2.4.3. Urine
18.9.2.4.4. Other body fluids
18.9.2.5.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric
Throughput
18.9.2.5.1. 400/800 with ISE
18.9.2.4.2.
800/1,200 with ISE
18.9.2.4.3. Up to 8,000 test/hour
18.9.2.4.4.
Up to 9,800 test/hour with dual ISE 18.9.2.4.5. Others
18.9.2.6.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
18.9.2.6.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.2.6.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.2.6.3. 400 samples (2 x 20 rack
set)
18.9.2.6.4. Others
18.9.2.7.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
18.9.2.7.1. Diabetes
18.9.2.7.2.
Testing for metabolic
functions or cardiac markers
18.9.2.6.3. Drugs-of-abuse testing
18.9.2.6.4.
18.9.2.8.
UAE Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
18.9.2.8.1.
Physician Office Laboratory
18.9.2.7.2. Hospital Laboratory
18.9.2.7.3. Point-of-care clinics
18.9.2.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.2.7.5. Core Laboratory
18.9.2.7.6.
Reference Laboratory 18.9.2.7.7. Integrated Delivery Network 18.9.2.7.8. Others
18.9.3.
Egypt
18.9.3.1.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.9.3.1.1.
Photometric and colorimetric
testing 18.9.3.1.2. Ion-selective potentiometry
18.9.3.1.3. Latex agglutination
18.9.3.1.4. Others
18.9.3.2.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
18.9.3.2.1. Automated
18.9.3.2.2. Benchtop Analyzer
18.9.3.2.3. Others
18.9.3.3.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
18.9.3.3.1. Serum
18.9.3.3.2. Plasma
18.9.3.3.3. Urine
18.9.3.3.4. Other body fluids
18.9.3.4.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
18.9.3.4.1. 400/800 with ISE
18.9.3.4.2.
800/1,200 with ISE
18.9.3.4.3. Up to 8,000 test/hour
18.9.3.4.4.
Up to 9,800 test/hour with dual ISE 18.9.3.4.5. Others
18.9.3.5.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
18.9.3.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.3.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.3.5.3. 400 samples (2 x 20 rack
set)
18.9.3.5.4. Others
18.9.3.6.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
18.9.3.6.1. Diabetes
18.9.3.6.2.
Testing for metabolic
functions or cardiac markers
18.9.3.6.3. Drugs-of-abuse testing
18.9.3.6.4.
18.9.3.7.
Egypt Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
18.9.3.7.1.
Physician Office Laboratory
18.9.3.7.2. Hospital Laboratory
18.9.3.7.3. Point-of-care clinics
18.9.3.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.3.7.5. Core Laboratory
18.9.3.7.6.
Reference Laboratory 18.9.3.7.7. Integrated Delivery Network 18.9.3.7.8. Others
18.9.4.
Kuwait
18.9.4.1.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
18.9.4.1.1.
Photometric and colorimetric
testing 18.9.4.1.2. Ion-selective potentiometry
18.9.4.1.3. Latex agglutination
18.9.4.1.4. Others
18.9.4.2.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
18.9.4.2.1. Automated
18.9.4.2.2. Benchtop Analyzer
18.9.4.2.3. Others
18.9.4.3.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
18.9.4.3.1. Serum
18.9.4.3.2. Plasma
18.9.4.3.3. Urine
18.9.4.3.4. Other body fluids
18.9.4.4.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
18.9.4.4.1. 400/800 with ISE
18.9.4.4.2.
800/1,200 with ISE
18.9.4.4.3. Up to 8,000 test/hour
18.9.4.4.4.
Up to 9,800 test/hour with dual ISE 18.9.4.4.5. Others
18.9.4.5.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
18.9.4.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.4.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.4.5.3. 400 samples (2 x 20 rack
set)
18.9.4.5.4. Others
18.9.4.6.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
18.9.4.6.1. Diabetes
18.9.4.6.2.
Testing for metabolic
functions or cardiac markers
18.9.4.6.3. Drugs-of-abuse testing
18.9.4.6.4.
18.9.4.7.
Kuwait Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
18.9.4.7.1.
Physician Office Laboratory
18.9.4.7.2. Hospital Laboratory
18.9.4.7.3. Point-of-care clinics
18.9.4.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.4.7.5. Core Laboratory
18.9.4.7.6.
Reference Laboratory 18.9.4.7.7. Integrated Delivery Network 18.9.4.7.8. Others
18.9.5. South Africa
18.9.5.1.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.9.5.1.1.
Photometric and colorimetric
testing 18.9.5.1.2. Ion-selective potentiometry
18.9.5.1.3. Latex agglutination
18.9.5.1.4. Others
18.9.5.2.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Type
18.9.5.2.1. Automated
18.9.5.2.2. Benchtop Analyzer
18.9.5.2.3. Others
18.9.5.3.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Substances
18.9.5.3.1. Serum
18.9.5.3.2. Plasma
18.9.5.3.3. Urine
18.9.5.3.4. Other body fluids
18.9.5.4.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Photometric
Throughput
18.9.5.4.1. 400/800 with ISE
18.9.5.4.2.
800/1,200 with ISE
18.9.5.4.3. Up to 8,000 test/hour
18.9.5.4.4.
Up to 9,800 test/hour with dual ISE 18.9.5.4.5. Others
18.9.5.5.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Sample Load
Capacity
18.9.5.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.5.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.5.5.3. 400 samples (2 x 20 rack
set)
18.9.5.5.4. Others
18.9.5.6.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By Application
18.9.5.6.1. Diabetes
18.9.5.6.2.
Testing for metabolic
functions or cardiac markers
18.9.5.6.3. Drugs-of-abuse testing
18.9.5.6.4.
18.9.5.7.
South Africa Clinical Chemistry Analyzer Market
Revenue (US$ Mn) and Forecasts, By End User
18.9.5.7.1. Physician Office Laboratory
18.9.5.7.2. Hospital Laboratory
18.9.5.7.3. Point-of-care clinics
18.9.5.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.5.7.5. Core Laboratory
18.9.5.7.6.
Reference Laboratory 18.9.5.7.7. Integrated Delivery Network 18.9.5.7.8. Others
18.9.6. Rest of Middle
East & Africa
18.9.6.1.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
18.9.6.1.1.
Photometric and colorimetric
testing 18.9.6.1.2. Ion-selective potentiometry
18.9.6.1.3. Latex agglutination
18.9.6.1.4. Others
18.9.6.2.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
18.9.6.2.1. Automated
18.9.6.2.2. Benchtop Analyzer
18.9.6.2.3. Others
18.9.6.3.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
18.9.6.3.1. Serum
18.9.6.3.2. Plasma
18.9.6.3.3. Urine
18.9.6.3.4. Other body fluids
18.9.6.4.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
18.9.6.4.1. 400/800 with ISE
18.9.6.4.2.
800/1,200 with ISE
18.9.6.4.3. Up to 8,000 test/hour
18.9.6.4.4.
Up to 9,800 test/hour with dual ISE 18.9.6.4.5. Others
18.9.6.5.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
18.9.6.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
18.9.6.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
18.9.6.5.3. 400 samples (2 x 20 rack
set)
18.9.6.5.4. Others
18.9.6.6.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
18.9.6.6.1. Diabetes
18.9.6.6.2.
Testing for metabolic
functions or cardiac markers
18.9.6.6.3. Drugs-of-abuse testing
18.9.6.6.4.
18.9.6.7.
Rest of Middle
East & Africa Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
18.9.6.7.1.
Physician Office Laboratory
18.9.6.7.2. Hospital Laboratory
18.9.6.7.3. Point-of-care clinics
18.9.6.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
18.9.6.7.5. Core Laboratory
18.9.6.7.6.
Reference Laboratory 18.9.6.7.7. Integrated Delivery Network 18.9.6.7.8. Others
18.10. Key Segment for
Channeling Investments
18.10.1.
By Country
18.10.2. By Measurement Technologies
18.10.3.
By Type
18.10.4.
By Substances
18.10.5.
By
Photometric Throughput
18.10.6.
By
Sample Load Capacity
18.10.7.
By Application
18.10.8. By End User
19. Latin
America Clinical Chemistry Analyzer Market Analysis and Forecasts, 2022 – 2030
19.1.
Overview
19.1.1.
Latin
America Clinical Chemistry Analyzer Market Revenue
(US$ Mn)
19.2. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Measurement Technologies
19.2.1.
Photometric
and colorimetric testing
19.2.2.
Ion-selective potentiometry
19.2.3.
Latex agglutination
19.2.4.
Others
19.3. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Type
19.3.1.
Automated
19.3.2.
Benchtop Analyzer
19.3.3.
Others
19.4. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Substances
19.4.1.
Serum
19.4.2.
Plasma
19.4.3.
Urine
19.4.4.
Other
body fluids
19.5. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Photometric Throughput
19.5.1.
400/800
with ISE
19.5.2.
800/1,200 with ISE
19.5.3. Up to 8,000 test/hour
19.5.4. Up to 9,800 test/hour with
dual ISE
19.5.5. Others
19.6. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Sample
Load Capacity
19.6.1.
80
(8 racks x 10 samples), 22 samples by carousel
19.6.2.
150
(15 racks x 10 samples), 22 samples
by carousel
19.6.3.
400
samples (2 x 20 rack set)
19.6.4.
Others
19.7. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By
Application
19.7.1.
Diabetes
19.7.2.
Testing
for metabolic functions or cardiac markers
19.7.3. Drugs-of-abuse testing
19.7.4.
19.8. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By End User
19.8.1.
Physician
Office Laboratory
19.8.2.
Hospital Laboratory
19.8.3.
Point-of-care clinics
19.8.4. University and Research Institutes, Veterinary
Laboratories and Food and Wine
Laboratories
19.8.5.
Core Laboratory
19.8.6.
Reference Laboratory
19.8.7.
Integrated
Delivery Network
19.8.8.
Others
19.9. Latin America Clinical
Chemistry Analyzer Market Revenue
(US$ Mn) and Forecasts, By Country
19.9.1.
Brazil
19.9.1.1.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Measurement Technologies
19.9.1.1.1.
Photometric and colorimetric
testing 19.9.1.1.2. Ion-selective potentiometry
19.9.1.1.3. Latex agglutination
19.9.1.1.4. Others
19.9.1.2.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Type
19.9.1.2.1. Automated
19.9.1.2.2. Benchtop Analyzer
19.9.1.2.3. Others
19.9.1.3.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Substances
19.9.1.3.1. Serum
19.9.1.3.2. Plasma
19.9.1.3.3. Urine
19.9.1.3.4. Other body fluids
19.9.1.4.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Photometric Throughput
19.9.1.4.1. 400/800 with ISE
19.9.1.4.2. 800/1,200
with ISE
19.9.1.4.3. Up to 8,000 test/hour
19.9.1.4.4.
Up to 9,800 test/hour with dual ISE 19.9.1.4.5. Others
19.9.1.5.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Sample Load Capacity
19.9.1.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
19.9.1.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
19.9.1.5.3. 400 samples (2 x 20 rack
set)
19.9.1.5.4. Others
19.9.1.6.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By Application
19.9.1.6.1. Diabetes
19.9.1.6.2.
Testing for metabolic
functions or cardiac markers
19.9.1.6.3. Drugs-of-abuse testing
19.9.1.6.4.
19.9.1.7.
Brazil Clinical Chemistry Analyzer Market Revenue (US$
Mn) and Forecasts, By End User
19.9.1.7.1.
Physician Office Laboratory
19.9.1.7.2. Hospital Laboratory
19.9.1.7.3. Point-of-care clinics
19.9.1.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
19.9.1.7.5. Core Laboratory
19.9.1.7.6.
Reference Laboratory 19.9.1.7.7. Integrated Delivery Network 19.9.1.7.8. Others
19.9.2. Argentina
19.9.2.1.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Measurement Technologies
19.9.2.1.1.
Photometric and colorimetric
testing 19.9.2.1.2. Ion-selective potentiometry
19.9.2.1.3. Latex agglutination
19.9.2.1.4. Others
19.9.2.2.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
19.9.2.2.1. Automated
19.9.2.2.2. Benchtop Analyzer
19.9.2.2.3. Others
19.9.2.3.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
19.9.2.3.1. Serum
19.9.2.3.2. Plasma
19.9.2.3.3. Urine
19.9.2.3.4. Other body fluids
19.9.2.4.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Photometric Throughput
19.9.2.4.1. 400/800 with ISE
19.9.2.4.2.
800/1,200 with ISE
19.9.2.4.3. Up to 8,000 test/hour
19.9.2.4.4.
Up to 9,800 test/hour with dual ISE 19.9.2.4.5. Others
19.9.2.5.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Sample Load Capacity
19.9.2.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
19.9.2.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
19.9.2.5.3. 400 samples (2 x 20 rack
set)
19.9.2.5.4. Others
19.9.2.6.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
19.9.2.6.1. Diabetes
19.9.2.6.2.
Testing for metabolic
functions or cardiac markers
19.9.2.6.3. Drugs-of-abuse testing
19.9.2.6.4.
19.9.2.7.
Argentina Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By End User
19.9.2.7.1.
Physician Office Laboratory
19.9.2.7.2. Hospital Laboratory
19.9.2.7.3. Point-of-care clinics
19.9.2.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
19.9.2.7.5. Core Laboratory
19.9.2.7.6.
Reference Laboratory 19.9.2.7.7. Integrated Delivery Network 19.9.2.7.8. Others
19.9.3. Rest of Latin America
19.9.3.1.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Measurement Technologies
19.9.3.1.1.
Photometric and colorimetric
testing 19.9.3.1.2. Ion-selective potentiometry
19.9.3.1.3. Latex agglutination
19.9.3.1.4. Others
19.9.3.2.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Type
19.9.3.2.1. Automated
19.9.3.2.2. Benchtop Analyzer
19.9.3.2.3. Others
19.9.3.3.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Substances
19.9.3.3.1. Serum
19.9.3.3.2. Plasma
19.9.3.3.3. Urine
19.9.3.3.4. Other body fluids
19.9.3.4.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Photometric Throughput
19.9.3.4.1. 400/800 with ISE
19.9.3.4.2.
800/1,200 with ISE
19.9.3.4.3. Up to 8,000 test/hour
19.9.3.4.4.
Up to 9,800 test/hour with dual ISE 19.9.3.4.5. Others
19.9.3.5.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
Sample Load Capacity
19.9.3.5.1. 80 (8 racks x 10 samples), 22 samples
by carousel
19.9.3.5.2. 150 (15 racks x 10 samples),
22 samples by carousel
19.9.3.5.3. 400 samples (2 x 20 rack
set)
19.9.3.5.4. Others
19.9.3.6.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By Application
19.9.3.6.1. Diabetes
19.9.3.6.2.
Testing for metabolic
functions or cardiac markers
19.9.3.6.3. Drugs-of-abuse testing
19.9.3.6.4.
19.9.3.7.
Rest of Latin
America Clinical Chemistry Analyzer Market Revenue (US$ Mn) and Forecasts, By
End User
19.9.3.7.1.
Physician Office Laboratory
19.9.3.7.2. Hospital Laboratory
19.9.3.7.3. Point-of-care clinics
19.9.3.7.4.
University and Research
Institutes, Veterinary Laboratories and Food and Wine Laboratories
19.9.3.7.5. Core Laboratory
19.9.3.7.6.
Reference Laboratory 19.9.3.7.7. Integrated Delivery Network 19.9.3.7.8. Others
19.10. Key Segment for
Channeling Investments
19.10.1.
By Country
19.10.2. By Measurement Technologies
19.10.3.
By Type
19.10.4. By Substances
19.10.5.
By
Photometric Throughput
19.10.6.
By
Sample Load Capacity
19.10.7. By Application
19.10.8.
By
End User
20. Competitive Benchmarking
20.1.
Market Share Analysis, 2021
20.2.
Global
Presence and Growth Strategies
20.2.1.
Mergers and Acquisitions
20.2.2.
Product Launches
20.2.3.
Investments Trends
20.2.4.
R&D
Initiatives
21. Player Profiles
21.1.
Abbott
21.1.1.
Company Details
21.1.2.
Company Overview
21.1.3.
Product Offerings
21.1.4.
Key Developments
21.1.5.
Financial Analysis
21.1.6.
SWOT Analysis
21.1.7.
Business
Strategies
21.2.
Beckman
Coulter, Inc.
21.2.1.
Company Details
21.2.2.
Company Overview
21.2.3.
Product Offerings
21.2.4.
Key Developments
21.2.5.
Financial Analysis
21.2.6.
SWOT Analysis
21.2.7.
Business
Strategies
21.3.
Cardinal
Health
21.3.1.
Company Details
21.3.2.
Company Overview
21.3.3.
Product Offerings
21.3.4.
Key Developments
21.3.5.
Financial Analysis
21.3.6.
SWOT Analysis
21.3.7.
Business
Strategies
21.4.
F.
Hoffmann-La Roche Ltd.
21.4.1.
Company Details
21.4.2.
Company Overview
21.4.3.
Product Offerings
21.4.4.
Key Developments
21.4.5.
Financial Analysis
21.4.6.
SWOT Analysis
21.4.7.
Business
Strategies
21.5.
Hitachi
High-Tech Corporation
21.5.1.
Company Details
21.5.2.
Company Overview
21.5.3.
Product Offerings
21.5.4.
Key Developments
21.5.5.
Financial Analysis
21.5.6.
SWOT Analysis
21.5.7.
Business
Strategies
21.6.
HORIBA
Medical
21.6.1.
Company Details
21.6.2.
Company Overview
21.6.3.
Product Offerings
21.6.4.
Key Developments
21.6.5.
Financial Analysis
21.6.6.
SWOT Analysis
21.6.7.
Business
Strategies
21.7.
Mindray
Bio-Medical Electronics Co., Ltd.
21.7.1.
Company Details
21.7.2.
Company Overview
21.7.3.
Product Offerings
21.7.4.
Key Developments
21.7.5.
Financial Analysis
21.7.6.
SWOT Analysis
21.7.7.
Business
Strategies
21.8.
MNCHIP
Technologies Co., Ltd.
21.8.1.
Company Details
21.8.2.
Company Overview
21.8.3.
Product Offerings
21.8.4.
Key Developments
21.8.5.
Financial Analysis
21.8.6.
SWOT Analysis
21.8.7.
Business
Strategies
21.9.
Ortho
Clinical Diagnostics
21.9.1.
Company Details
21.9.2.
Company Overview
21.9.3.
Product Offerings
21.9.4.
Key Developments
21.9.5.
Financial Analysis
21.9.6.
SWOT Analysis
21.9.7.
Business
Strategies
21.10.
Randox
Laboratories Ltd.
21.10.1.
Company Details
21.10.2.
Company Overview
21.10.3.
Product Offerings
21.10.4.
Key Developments
21.10.5.
Financial Analysis
21.10.6.
SWOT Analysis
21.10.7.
Business
Strategies
21.11.
Siemens
Healthcare GmbH
21.11.1.
Company Details
21.11.2.
Company Overview
21.11.3.
Product Offerings
21.11.4.
Key Developments
21.11.5.
Financial Analysis
21.11.6.
SWOT Analysis
21.11.7.
Business
Strategies
21.12.
Thermo
Fisher Scientific Inc
21.12.1.
Company Details
21.12.2.
Company Overview
21.12.3.
Product Offerings
21.12.4.
Key Developments
21.12.5.
Financial Analysis
21.12.6.
SWOT Analysis
21.12.7.
Business
Strategies
21.13.
Trivitron
Healthcare
21.13.1.
Company Details
21.13.2.
Company Overview
21.13.3.
Product Offerings
21.13.4.
Key Developments
21.13.5.
Financial Analysis
21.13.6.
SWOT Analysis
21.13.7.
Business
Strategies
21.14.
Other
Market Participants
22. Key Findings
Note: This
ToC is tentative and can be changed according to the research study conducted during the course of report
completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
